Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19
Interim guidance
18 August 2022
| COVID-19: Vaccines
Overview
These WHO interim recommendations on the use of the mRNA-1273 vaccine (Moderna) against COVID-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
This document has been updated: Version 18 August 2022.
For translations of this document in other languages, click here.
- Interim recommendations for use of the mRNA–1273 vaccine. Version 23 February 2022.
- Interim recommendations for use of the mRNA–1273 vaccine. Version 19 November 2021.
- Interim recommendations for use of the mRNA–1273 vaccine. Version 15 June 2021.
- Interim recommendations for use of the mRNA–1273 vaccine. Version 25 January 2021.
WHO Team
Agenda, Policy & Strategy (APS),
Immunization, Vaccines and Biologicals (IVB),
Strategic Advisory Group of Experts on Immunization
Editors
World Health Organization
Number of pages
19
Reference numbers
WHO Reference Number: WHO/2019-nCoV/vaccines/SAGE_recommendation/mRNA-1273/2021.3
Copyright
